+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Forecast 2024-2030- Product Image
Global Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Forecast 2024-2030- Product Image
Sale

Global Immunofluorescence Assay Market by Products (Antibodies, Consumables & Accessories, Instruments), Type (Direct Immunofluorescence, Indirect Immunofluorescence), Disease, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 196 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5674780
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Immunofluorescence Assay Market size was estimated at USD 3.98 billion in 2023, USD 4.14 billion in 2024, and is expected to grow at a CAGR of 5.51% to reach USD 5.80 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Immunofluorescence Assay Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Immunofluorescence Assay Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Immunofluorescence Assay Market, highlighting leading vendors and their innovative profiles. These include Abnova Corporation, AESKU.GROUP GmbH & Co. KG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bruker Corporation, Cell Signaling Technology, Inc., Cellabs, Elabscience Biotechnology Inc., Enzo Biochem, Inc., J. Mitra & Co. Pvt. Ltd., Maravai LifeSciences Inc., Merck KGaA, Olympus Corporation, PerkinElmer Inc., Thermo Fisher Scientific, Inc., and Zyagen, Inc.

Market Segmentation & Coverage

This research report categorizes the Immunofluorescence Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Products
    • Antibodies
    • Consumables & Accessories
    • Instruments
    • Kits
    • Reagents
  • Type
    • Direct Immunofluorescence
    • Indirect Immunofluorescence
  • Disease
    • Autoimmune Diseases
    • Cancer
    • Cardiovascular Diseases
    • Infectious Diseases
  • End-User
    • Academic & Research Institutes
    • Contract Research Organizations
    • Hospitals & Diagnostic Centers
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Immunofluorescence Assay Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Immunofluorescence Assay Market?
  3. What are the technology trends and regulatory frameworks in the Immunofluorescence Assay Market?
  4. What is the market share of the leading vendors in the Immunofluorescence Assay Market?
  5. Which modes and strategic moves are suitable for entering the Immunofluorescence Assay Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Immunofluorescence Assay Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of chronic disease across the world
5.1.1.2. Increasing government support by providing funds and budget in cancer diagnostics improvement
5.1.1.3. Growing awareness of early detection and treatment of cancer
5.1.2. Restraints
5.1.2.1. Concern associated with quality research of antibodies and high instrumental cost
5.1.3. Opportunities
5.1.3.1. Increasing product approvals and favorable reimbursements
5.1.3.2. Introduction of modern methods to use immunofluorescence assay
5.1.4. Challenges
5.1.4.1. Dearth of skilled healthcare professionals globally
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Immunofluorescence Assay Market, by Products
6.1. Introduction
6.2. Antibodies
6.3. Consumables & Accessories
6.4. Instruments
6.5. Kits
6.6. Reagents
7. Immunofluorescence Assay Market, by Type
7.1. Introduction
7.2. Direct Immunofluorescence
7.3. Indirect Immunofluorescence
8. Immunofluorescence Assay Market, by Disease
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Cardiovascular Diseases
8.5. Infectious Diseases
9. Immunofluorescence Assay Market, by End-User
9.1. Introduction
9.2. Academic & Research Institutes
9.3. Contract Research Organizations
9.4. Hospitals & Diagnostic Centers
9.5. Pharmaceutical & Biotechnology Companies
10. Americas Immunofluorescence Assay Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Immunofluorescence Assay Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Immunofluorescence Assay Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abnova Corporation
14.1.2. AESKU.GROUP GmbH & Co. KG
14.1.3. Becton, Dickinson and Company
14.1.4. Bio-Rad Laboratories, Inc.
14.1.5. Bruker Corporation
14.1.6. Cell Signaling Technology, Inc.
14.1.7. Cellabs
14.1.8. Elabscience Biotechnology Inc.
14.1.9. Enzo Biochem, Inc.
14.1.10. J. Mitra & Co. Pvt. Ltd.
14.1.11. Maravai LifeSciences Inc.
14.1.12. Merck KGaA
14.1.13. Olympus Corporation
14.1.14. PerkinElmer Inc.
14.1.15. Thermo Fisher Scientific, Inc.
14.1.16. Zyagen, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. IMMUNOFLUORESCENCE ASSAY MARKET RESEARCH PROCESS
FIGURE 2. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2023 VS 2030
FIGURE 3. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. IMMUNOFLUORESCENCE ASSAY MARKET DYNAMICS
FIGURE 7. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
FIGURE 8. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 12. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. IMMUNOFLUORESCENCE ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. IMMUNOFLUORESCENCE ASSAY MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. IMMUNOFLUORESCENCE ASSAY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 6. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 12. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DIRECT IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY INDIRECT IMMUNOFLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 15. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 20. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 38. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 40. CANADA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 42. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 44. MEXICO IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 50. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 60. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 62. CHINA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 63. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 64. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 66. INDIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 72. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 74. JAPAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 96. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 98. THAILAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 109. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 113. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 115. EGYPT IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 117. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 119. FINLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 121. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 125. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 133. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 135. ITALY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 145. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 147. NORWAY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 149. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 151. POLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 153. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 155. QATAR IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 169. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 181. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 183. TURKEY IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 188. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM IMMUNOFLUORESCENCE ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. IMMUNOFLUORESCENCE ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 193. IMMUNOFLUORESCENCE ASSAY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 194. IMMUNOFLUORESCENCE ASSAY MARKET LICENSE & PRICING

Companies Mentioned

  • Abnova Corporation
  • AESKU.GROUP GmbH & Co. KG
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cell Signaling Technology, Inc.
  • Cellabs
  • Elabscience Biotechnology Inc.
  • Enzo Biochem, Inc.
  • J. Mitra & Co. Pvt. Ltd.
  • Maravai LifeSciences Inc.
  • Merck KGaA
  • Olympus Corporation
  • PerkinElmer Inc.
  • Thermo Fisher Scientific, Inc.
  • Zyagen, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages196
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.14 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.8 Billion
Compound Annual Growth Rate5.5%
Regions CoveredGlobal
No. of Companies Mentioned16

Related Topics

Related Reports

Immunofluorescence Assay Global Market Report 2024 - Product Image

Immunofluorescence Assay Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Immunofluorescence Assay Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Immunofluorescence Assay Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 110 Pages
  • Global
From
Immunofluorescence Assays - Global Strategic Business Report - Product Image

Immunofluorescence Assays - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Global Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Forecast 2024-2030 - Product Image

Global Immunoprotein Diagnostic Testing Market by Technology (Enzyme-Linked Immunoassay, Immunofluorescence Assay, Radioimmunoassay), Immunoprotein Type (C-reactive Protein, Complement System Protein, Immunoglobulin), Application, End-User - Forecast 2024-2030

  • Report
  • 185 Pages
  • Global
From
Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2023-2030 - Product Image

Global Cystatin C Assay Market by Product (Analyzer, Kits, Reagents), Method (Chemiluminescence Immunoassay, Enzyme linked Immunosorbent Assay, Immunofluorescence Assay), Sample Type, Setting, Application, End-user - Forecast 2023-2030

  • Report
  • 188 Pages
  • Global
From

About the Immunofluorescence Assay Market

The Immunofluorescence Assay (IFA) market is a segment of the In Vitro Diagnostics (IVD) industry. It is used to detect the presence of antigens or antibodies in a sample, such as a blood or tissue sample. This type of assay is used to diagnose a variety of diseases, including autoimmune diseases, infectious diseases, and cancer. It is a highly sensitive and specific method of diagnosis, and is often used in combination with other diagnostic tests. IFA tests are typically performed in a laboratory setting, and require specialized equipment and reagents. The market is driven by the increasing prevalence of diseases, the growing demand for accurate and timely diagnosis, and the development of new technologies. Some of the major players in the Immunofluorescence Assay market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Danaher Corporation, and Roche Diagnostics. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.